Eton Pharmaceuticals Inc.

ETON | NASDAQ

Price Alert Chart Builder DCF Calculator

$56.86

+$1.55 (+2.80%)

Sep 22, 2026, 10:58 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	37.59M	24.27M	21.28M	22.46M	18.93M	17.28M	11.65M	10.32M	9.07M	7.97M	7.31M	7.03M	12M	5.3M	8.5M	3.22M	7.36M	2.18M	6.09M	775K	3.07M	11.9M
Cost of Revenue	12.18M	9.53M	8.18M	14.6M	7M	7.42M	5.17M	4.02M	3.45M	2.96M	3.68M	2.63M	2.32M	1.96M	2.14M	1.2M	2.75M	718K	280K	617K	136K	1.59M
Gross Profit	25.41M	14.74M	13.1M	7.86M	11.92M	9.86M	6.48M	6.3M	5.63M	5.01M	3.63M	4.4M	9.68M	3.35M	6.36M	2.02M	4.61M	1.46M	5.81M	158K	2.93M	10.31M
Operating Income	12.79M	2.41M	2.46M	-1.36M	-1.48M	-470K	629K	509K	-2.94M	-800K	-1.99M	-548K	3.88M	-2.53M	1.06M	-2.9M	-1.34M	-5.09M	1.31M	-5.85M	-2.33M	5.36M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	11.72M	1.57M	1.41M	-1.96M	-2.52M	-1.5M	-511K	501K	-2.99M	-811K	-2.01M	-579K	4.56M	-2.66M	912K	-3.05M	-1.56M	-5.33M	1.04M	-6.09M	-2.02M	5.12M
Net Income	11.58M	1.55M	1.48M	-1.93M	-2.59M	-1.57M	-598K	627K	-3.04M	-811K	-2.26M	-579K	4.56M	-2.66M	912K	-3.05M	-1.56M	-5.33M	1.04M	-6.09M	-2.02M	5.12M
Selling & General & Admin	11.63M	10.45M	8.86M	8.11M	9.69M	9.17M	6.72M	5.29M	5.59M	5.16M	4.58M	4.34M	4.67M	5.35M	4.35M	4.17M	5.26M	4.93M	3.82M	3.33M	3.27M	4.06M
Research & Development	993K	1.88M	1.78M	1.11M	3.71M	1.16M	-871K	505K	2.97M	651K	1.05M	615K	1.13M	535K	944K	744K	690K	1.62M	681K	2.68M	1.99M	886K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	12.62M	12.32M	10.64M	9.22M	13.4M	10.33M	5.85M	5.79M	8.56M	5.81M	5.62M	4.95M	5.8M	5.88M	5.3M	4.91M	5.95M	6.55M	4.5M	6.01M	5.26M	4.94M
Interest Expense	1.08M	-840K	1.21M	1.21M	1.2M	1.16M	1.33M	8K	52K	11K	361K	31K	124K	126K	256K	150K	218K	243K	275K	247K	237K	247K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	24.8M	21.85M	18.82M	23.82M	20.4M	17.75M	11.02M	9.82M	12.01M	8.77M	9.31M	7.58M	8.11M	7.84M	7.44M	6.11M	8.7M	7.26M	4.78M	6.62M	5.39M	6.53M
Income Tax Expense	140K	20K	-69K	-28K	66K	74K	87K	-126K	54K	n/a	247K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	27.64M	27.29M	26.91M	26.89M	26.89M	26.89M	26.14M	25.9M	25.78M	25.76M	25.74M	25.72M	25.59M	25.53M	25.38M	25.37M	25.13M	25.3M	25.29M	25.28M	25.2M	24.45M
Shares Outstanding (Diluted)	32.79M	31.55M	26.91M	26.89M	26.89M	26.89M	26.14M	26.55M	25.78M	25.76M	25.74M	25.72M	25.98M	25.53M	25.69M	25.37M	25.13M	25.3M	25.96M	25.28M	25.21M	26.55M
EPS (Basic)	0.42	0.06	0.06	-0.07	-0.10	-0.06	-0.02	0.02	-0.12	-0.03	-0.09	-0.02	0.18	-0.11	0.04	-0.13	-0.06	-0.22	0.04	-0.24	-0.08	0.21
EPS (Diluted)	0.35	0.05	0.05	-0.07	-0.10	-0.06	-0.02	0.02	-0.12	-0.03	-0.09	-0.02	0.18	-0.11	0.04	-0.13	-0.06	-0.22	0.04	-0.24	-0.08	0.19
EBITDA	12.79M	1.87M	3.64M	266K	-316K	678K	-156K	787K	-2.66M	-566K	-2.52M	-357K	4.86M	-2.32M	1.42M	-2.73M	-169K	-4.91M	1.45M	-5.76M	-1.69M	5.52M
EBIT	12.79M	734K	2.62M	-743K	-1.32M	-335K	-511K	509K	-2.94M	-800K	-2.79M	-548K	4.68M	-2.53M	1.17M	-2.9M	-1.34M	-5.09M	1.31M	-5.85M	-1.78M	5.36M
Depreciation & Amortization	n/a	1.13M	1.02M	1.01M	1.01M	1.01M	355K	278K	279K	234K	275K	191K	172K	213K	252K	170K	1.17M	181K	137K	85K	85K	155K